Pill before surgery may reduce scarring for skin cancer patients
NCT ID NCT03534947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether taking a daily pill called sonidegib for 12 weeks could shrink basal cell carcinomas in cosmetically sensitive areas like the face. The goal was to make surgery less invasive, reduce scarring, or even avoid surgery altogether by using only a topical cream afterward. Sixteen adults with this type of skin cancer participated in the pilot study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Melanoma Institute Australia
North Sydney, New South Wales, 2060, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Botox before the knife: could a Pre-Surgery injection lead to Better-Looking scars?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- Night shift workers' skin may struggle to fix sun damage, study suggests
- New skin patch could speed recovery after skin cancer removal
- What makes skin cancer patients happy after surgery?
- AI reads skin lesions to predict cancer aggressiveness